Reglan Lawsuit News and Information
Reglan Lawsuits
Reglan side effects have been associated with the development of tardive dyskinesia, a syndrome that causes involuntary movements in the body extremities, particularly the lower face. In February 2009, the FDA required that a “black box” warning about the tardive dyskinesia problems be added to Reglan and other gastrointestinal drugs containing metoclopramide.
All Articles Tagged With: "Reglan"
Generic Reglan Tardive Dyskinesia Lawsuit Not Preempted: Appeals Court
The U.S. Court of Appeals for the Firth Circuit has rejected the argument by a generic drug maker that federal law preempts a state-law failure-to-warn claim filed by a user of their generic Reglan, who developed the rare movement disorder tardive dyskinesia.
Reglan Lawsuit Over Use of Generics Results in Dismissal of Original Makers
Wyeth, Inc. and Schwarz Pharma, Inc. have been dismissed from a Reglan lawsuit filed by a woman who developed a rare movement disorder, known as tardive dyskinsia, after using a generic version of their gastrointestinal drug. The failure to warn case will now proceed against only the makers of generic Reglan.
Metoclopramide Tardive Dyskinesia Warnings Accompany New Tablets
A new orally disintegrating version of metoclopramide tablets, a generic variation of Reglan that Salix Pharmaceuticals, Ltd. received approval last week to begin marketing for treatment of diabetic gastroparesis and gastroesophageal reflux disease (GERD), will carry a “black box” warning about the risk of a serious movement disorder, known as tardive dyskinesia.
Reglan Pregnancy Use for Morning Sickness is Safe: Study
New research indicates that the anti-nausea drug metoclopramide, generally known by the brand name Reglan, is safe for short-term use among pregnant women to combat morning sickness.
Reglan Litigation Will Not Be Consolidated in MDL
The U.S. Judicial Panel on Multidistrict Litigation denied a request to consolidate the federal Reglan litigation over tardive dyskinesia and other neurological injuries associated with the long-term use of metoclopramide drugs.
Tardive Dyskinesia Lawsuit Filed Over Reglan in Arkansas
An Arkansas woman has filed a lawsuit against the manufacturers of Reglan over her development of tardive dyskinesia, a movement disorder that causes uncontrollable movements or ticks, which she alleges was caused by side effects of gastrointestinal drug.
Reglan (Metoclopramide) Lawsuit Consolidation Being Considered Today
The U.S. Judicial Panel on Multidistrict Litigation is scheduled to hear oral arguments today about whether to consolidate all lawsuits involving Reglan and generic metoclopramide drugs, which have been linked to an increased risk of a serious movement disorder known as tardive dyskinesia.
Reglan Problems Linked to 106 Cases of Movement Disorders
According to a recent report, at least 106 cases of tardive dyskinesia and other movement disorder problems have been reported to the FDA Adverse Event Reporting System among users of Reglan and other metoclopramide drugs.
Generic Reglan Lawsuit Appeal Request Denied in Vermont
Four generic drug makers named as defendants in a Reglan lawsuit pending in the U.S. District Court for the District of Vermont have been denied the opportunity to pursue an immediate appeal the Court’s decision not to grant their motion for summary judgment, which was filed on the basis that they did not develop the [...]
Motion Filed to Consolidate Reglan Tardive Dyskinesia Lawsuits
The plaintiffs in all of the known tardive dyskinesia lawsuits filed against the makers of Reglan and other Metoclopramide-containing drugs, have filed a motion with the U.S. Judicial Panel on Multidistrict Litigation to transfer the actions from different federal courts throughout the country to the District of Nevada for coordinated and consolidated pretrial proceedings. [...]
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
